30 Spring Mill Drive Malvern, PA 19355 venatorx.com
Note: Revenues for privately held companies are statistical evaluations.
Venatorx Pharmaceuticals's annual revenues are $10-$50 million (see exact revenue data) and has 10-100 employees. It is classified as operating in the Scientific Research & Development Services industry.
Note: Venatorx Pharmaceuticals's revenues are gauged from an analysis of company filings.
Investor Activity
Venatorx Pharmaceuticals has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
Date
Investors
Percent Raised
Target Size
July 13, 2023
3
73%
$48 MM
Complete list of funding rounds and total amounts in the Company Report
Venatorx Pharmaceuticals's Income Statement (based on Industry Averages)
$ Millions (Industry Average)
Venatorx Pharmaceuticals Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
Trademark Applications
Trademark applications show the products and services that Venatorx Pharmaceuticals is developing and marketing.
Venatorx Pharmaceuticals's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
FEPTANBLI antibiotic pharmaceutical preparation
12/22/2023
VENATORX Pharmaceuticals, namely, anti-infective agents and antibacterials; Diagnostic agents, preparations and substances for medical purposes
10/08/2013
See all trademarks and details in the Full Report.
Recession Risk
Determine whether Venatorx Pharmaceuticals grew or shrank during the last recession. This is useful in estimating the
financial strength and credit risk of the company.
Compare how recession-proof Venatorx Pharmaceuticals is relative to the industry overall.
While a new recession may strike a particular industry, measuring the
industry and company's robustness during the last recession estimates its ability to weather future recessions.
Market Share of Venatorx Pharmaceuticals's Largest Competitors
A competitive analysis shows these companies are in the same general field as Venatorx Pharmaceuticals, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Venatorx Pharmaceuticals.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Venatorx Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.